HP

HealthInvest Partners Portfolio holdings

AUM $234M
1-Year Return 10.88%
This Quarter Return
+2.67%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$234M
AUM Growth
+$7.15M
Cap. Flow
+$16.2M
Cap. Flow %
6.93%
Top 10 Hldgs %
56.95%
Holding
38
New
1
Increased
23
Reduced
13
Closed
1

Top Buys

1
LLY icon
Eli Lilly
LLY
+$3.21M
2
SYK icon
Stryker
SYK
+$1.77M
3
ISRG icon
Intuitive Surgical
ISRG
+$1.75M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$1.57M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$1.51M

Top Sells

1
UNH icon
UnitedHealth
UNH
+$2.18M
2
ACLX icon
Arcellx
ACLX
+$1.21M
3
AMGN icon
Amgen
AMGN
+$749K
4
BSX icon
Boston Scientific
BSX
+$654K
5
KRYS icon
Krystal Biotech
KRYS
+$458K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NAMS icon
26
NewAmsterdam Pharma
NAMS
$3B
$2.85M 1.22%
157,223
+49,440
+46% +$895K
KRYS icon
27
Krystal Biotech
KRYS
$4.18B
$2.77M 1.19%
20,158
-3,333
-14% -$458K
HRMY icon
28
Harmony Biosciences
HRMY
$1.92B
$2.73M 1.17%
86,274
-5,027
-6% -$159K
AUTL
29
Autolus Therapeutics
AUTL
$381M
$2.52M 1.08%
1,105,461
+625,817
+130% +$1.43M
UNH icon
30
UnitedHealth
UNH
$320B
$2.49M 1.06%
13,727
-12,055
-47% -$2.18M
MREO
31
Mereo BioPharma
MREO
$290M
$2.07M 0.89%
764,901
+374,901
+96% +$1.02M
SMMT icon
32
Summit Therapeutics
SMMT
$13.8B
$1.97M 0.84%
92,737
-12,340
-12% -$263K
ACLX icon
33
Arcellx
ACLX
$4.31B
$1.69M 0.73%
25,732
-18,439
-42% -$1.21M
BCAX
34
Bicara Therapeutics Inc. Common Stock
BCAX
$654M
$1.37M 0.59%
147,380
+27,547
+23% +$256K
IRON icon
35
Disc Medicine
IRON
$2.1B
$1.31M 0.56%
+24,652
New +$1.31M
CRBP icon
36
Corbus Pharmaceuticals
CRBP
$116M
$1.21M 0.52%
175,582
+77,278
+79% +$533K
JANX icon
37
Janux Therapeutics
JANX
$1.51B
$1.15M 0.49%
49,820
+3,012
+6% +$69.6K
CABA icon
38
Cabaletta Bio
CABA
$166M
– –
-182,354
Closed -$253K
1
2